Richtlijn CVRM feb2013 - KNMP

Mantel 2004 Mantel-Teeuwisse A, Verschuren WMM, Klungel OH, De boer A en Kromhout D. Recent trends
in (under)treatment of hypercholesterolaemia in the Netherlands. Brit J Clin Pharm 2004; 58: 310-
316.
Mancini 2011 Mancini GBJ, Baker S, Bergeron J, Fitchett D, Frohlich J,Genest J,Gupta M, et al. Diagnosis,
Prevention, and Management of Statin Adverse Effects and Intolerance: Proceedings of an
Canadian Working Group Consensus Conference. Can J Cardiology 2011; 5 (27): 635-662.
Mangiapane 2011 Mangiapane S, Busse R. Prescription prevalence and continuing medication use for secondary
prevention after myocardial infarction: the reality of care revealed by claims data analysis.
Arztebl Int. 2011 Dec;108(50): 856-62.
Dtsch
Maningat 2011 Maningat P, Breslow JL. Needed: pragmatic clinical trials for statin intolerant patients. NEJM
2011;365(24):2250-1.
Mann 2010 Mann DM, Woodward M, Muntner P, Falzon L, Kronish I. Predictors of nonadherence to
statins: a systematic review and meta-analysis. Ann Pharmacother. 2010 Sep;44(9):1410.
Marelli 2011 Marelli C, Gunnarsson C, Ross S, Haas S, Stroup DF, Cload P, et al. Statins and risk of cancer.
A retrospective cohort analysis of 45,857 matched pairs from an electronic Medical Records
Database of 11 Million Adult Americans. Am Coll Cardiol 2011; 58: 530-537.
Marcoff 2007 Marcoff L, THompson PD. The role of Coenyme Q10 in statin-Associated Myopathy: A
systematic review. J Am Coll Cardiology 2007; 23 (49): 2231-2237.
McCullough 2011 McCullough PA, Ahmed AB, Zughaib MT, Glanz ED, Di Loreto MJ.treatment of
hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation
reduction in cardiovascular events. Rev Cardiovasc Med. 2011;12(4):173-85.
into a
McClure 2007 McClure DL, Valuck RJ, Glanz M, Hokanson JE. Systematic review and meta-analysis of
clinically relevant adverse events from HMG CoA reductase inhibitor trials worldwide from 1982
to present. Pharmacoepidemiol Drug Saf 2007; 16:132-43.
McPherson 1999 McPherson R. Comparative effects of simvastatin and cholestyramine on plasma lipoproteins
and CETP in humans. Can J Clin Pharmacol. 1999 Summer;6(2):85-90.
Meerum 2008
Meerum Terwogt JM, Koopmans RP, Roos YBWEM , van Montfrans GA. Angiotensine IIreceptorantagonisten
vergeleken met andere antihypertensiva: nog onvoldoende bewijs voor een
lager risico op herseninfarcten. Ned Tijdschr Geneeskd. 2008;152:71-5
Messerli 2006 Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A, Kolloch R, Benetos A,
Pepine CJ. Dogma disputed: can aggressively lowering bloodpressure in hypertensive patients
coronary heart disease be dangerous Ann Intern Med 2006; 144: 884-893
with
Mikhailidis 2011 Mikhailidis DP, Lawson RW, McCormick AL, Sibbring GC, Tershakovec AM, Davies GM, et al.
Comparative efficacy of the addition of ezetimibe to statin vs statin titration in patients with
hypercholesterolaemia: systematic review and meta-analysis. Curr Med Res Opin. 2011
;27(6):1191-210.
Miller 2012 Miller CS, Grandi SM, Shimony A, Filion KB, Eisenberg MJ. Meta-analysis of efficacy and safety
of new oral anticoagulants ( dabigatran, rivaroxaban, apixaban) versus warfarin in patients
with atrial fibrillation. Am J Cardiol 2012; PMID: 22537354
Morales 2011
Mourad 2004
Morales-Villegas EC, Di Sciascio G, Briguori C. Statins: Cardiovascualr Risk Reduction in Percutaneous
Coronary intervention- Basic and clinical evidence of hyperacute use of statins. Intern Journal of
Hypertension 2011; article ID 904742. Doi: 10.4061/2011/904742
Mourad JJ, Waeber B, Zannad F, Laville M, Duru G, Andrejak M. Comparison of differente therapeutic
strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential
monotherapy or a stepped-care approach. J Hypertens 2004; 22: 2379-2386.
Mulrow 2000 Mulrow CD, Chiquette E, Angel L et al. Dieting to reduce body weight for controlling
hypertension in adults. Cochrane Databse Syst Rev 2000; CD000484
Musini 2009
Musine VM, Fortin PM, Basset K, Wright JM. Blood pressure lowering efficacy of rennin inhibitors for
primary hypertension: a Cochrane systemic review. J of Human Hypertension 2009; 23: 495-502.
94
CONCEPT